The document summarizes the results of a joint venture between Eli Lilly and Boehringer Mannheim in Brazil from 1996 to 1999 to develop the diabetes business. It discusses the formation of the joint venture, market opportunities in Brazil, financial results including sales and market share increases of products like Humulin and Advantage glucose strips and meters, and concludes with a termination of the alliance in 1998 due to an acquisition.